These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17345087)

  • 21. Novel biomarkers and genomic tests in prostate cancer: a critical analysis.
    Falzarano SM; Ferro M; Bollito E; Klein EA; Carrieri G; Magi-Galluzzi C
    Minerva Urol Nefrol; 2015 Sep; 67(3):211-31. PubMed ID: 26054411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA density improves prediction of prostate cancer.
    Verma A; St Onge J; Dhillon K; Chorneyko A
    Can J Urol; 2014 Jun; 21(3):7312-21. PubMed ID: 24978363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early detection of prostate cancer: is serum PSA testing alone sufficient?].
    Börgermann C; Vom Dorp F; Breuer G; Kliner S; Rübben H
    Urologe A; 2010 Nov; 49(11):1351-5. PubMed ID: 20959954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Non- PSA serum markers for the diagnosis of PCa].
    Mengual L; Musquera M; Ciudin A; Ribal MJ
    Arch Esp Urol; 2015 Apr; 68(3):229-39. PubMed ID: 25948796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Problem Is Not What to Do with Indolent and Harmless Prostate Cancer-The Problem Is How to Avoid Finding These Cancers.
    Gandaglia G; Briganti A; Fossati N; Salonia A; Mottrie A; Catto J; Montorsi F
    Eur Urol; 2016 Oct; 70(4):547-548. PubMed ID: 26916048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.
    Carter HB
    Asian J Androl; 2012 May; 14(3):355-60. PubMed ID: 22343493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate Cancer and the Evolving Role of Biomarkers in Screening and Diagnosis.
    Rodriguez JF; Eggener SE
    Radiol Clin North Am; 2018 Mar; 56(2):187-196. PubMed ID: 29420975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of PSA in diagnosis of prostate cancer and its recurrence].
    Vergho DC; Heine K; Wolff JM
    Pathologe; 2005 Nov; 26(6):473-8. PubMed ID: 16215709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alternative tests to PSA for prostate cancer diagnosis].
    Defilippi E; Zitella A; Tizzani A
    Urologia; 2011; 78(2):75-81. PubMed ID: 21553390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.
    Bickers B; Aukim-Hastie C
    Anticancer Res; 2009 Aug; 29(8):3289-98. PubMed ID: 19661347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Words of wisdom. Re: PSA density improves prediction of prostate cancer.
    Roobol MJ
    Eur Urol; 2014 Nov; 66(5):964-5. PubMed ID: 25763443
    [No Abstract]   [Full Text] [Related]  

  • 33. 4-Kallikrein Test and Kallikrein Markers in Prostate Cancer Screening.
    McDonald ML; Parsons JK
    Urol Clin North Am; 2016 Feb; 43(1):39-46. PubMed ID: 26614027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood biomarkers for prostate cancer detection and prognosis.
    Shariat SF; Karam JA; Roehrborn CG
    Future Oncol; 2007 Aug; 3(4):449-61. PubMed ID: 17661720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiparametric MRI in the PSA screening era.
    George AK; Pinto PA; Rais-Bahrami S
    Biomed Res Int; 2014; 2014():465816. PubMed ID: 25250323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.
    Ito K; Fujizuka Y; Ishikura K; Cook B
    Int J Clin Oncol; 2014 Oct; 19(5):782-92. PubMed ID: 25135462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the best way not to treat prostate cancer?
    Leapman MS; Carroll PR
    Urol Oncol; 2017 Feb; 35(2):42-50. PubMed ID: 27746147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Related biomarkers in the diagnosis of prostate cancer].
    Xu YM; Liu HZ
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):937-40. PubMed ID: 26665686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostate-specific antigen and early detection of prostate cancer.
    Chu TM
    Tumour Biol; 1997; 18(2):123-34. PubMed ID: 9222310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The level of evidence for the use of biomarkers in the early detection of prostate cancer].
    Lamy PJ; Gauchez AS; Salomon L; Haugh M; Ceraline J; Fulla Y; Georges A; Larré S; Loric S; Luporsi E; Martin PM; Mazerolles C; Molinié V; Mongiat-Artus P; Piffret J; Thuillier F; Perrin P; Rebillard X;
    Ann Biol Clin (Paris); 2016; 74(2):227-32. PubMed ID: 27029727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.